Swiss biotech startup hephaistos.bio secured 161000 EUR (CHF 150000) from Venture Kick to accelerate the development of custom enzyme solutions for pharmaceutical and chemical manufacturing. The funding will support follow-up industrial enzyme design campaigns, expansion of laboratory automation capabilities, first hires, advancement of the enzyme design platform, and collaboration expansion with industrial partners.
About Hephaistos.bio
Swiss biotech startup developing custom enzyme solutions for pharmaceutical and chemical manufacturing. The company combines computational biology, chemistry, machine learning, and structural biology to design custom protein catalysts tailored to specific industrial processes through an end-to-end enzyme design platform.
Zurich, Switzerland
Read Company ProfileFrequently Asked Questions
What type of funding round did Hephaistos.bio raise?
Hephaistos.bio raised a grant round.
How much did Hephaistos.bio raise in its grant?
Hephaistos.bio raised $161,000 EUR in its grant.
When did Hephaistos.bio raise its grant?
Hephaistos.bio raised its grant on 2026-06-01.
Who invested in Hephaistos.bio's grant?
The investors in Hephaistos.bio's grant are: Venture Kick.
What type of investment was Hephaistos.bio's grant?
Hephaistos.bio's grant was a equity investment.
How will Hephaistos.bio use the funds from its grant?
Hephaistos.bio plans to use the funds for: follow-up industrial enzyme design campaigns, expansion of laboratory automation capabilities, first hires, advance the enzyme design platform, expand collaborations with industrial partners.